- Trials with a EudraCT protocol (7)
 - Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
 
		
	   		
	   		    
                    
                   	
                   	    7 result(s) found for: Confounders.
                    
                
			
   			
		
		Displaying page 1 of 1.
	
	
| EudraCT Number: 2007-004894-25 | Sponsor Protocol Number: ATCC10AA_IS_ICDJ10-J18 | Start Date*: 2009-06-30 | 
| Sponsor Name:Karolinska University Hospital Huddinge | ||
| Full Title: Effect of rosuvastatin on cardiovascular events and mortality after pneumonia | ||
| Medical condition: Community aquired pneumonia | ||
| Disease: | ||
| Population Age: | Gender: Male, Female | |
| Trial protocol: SE (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2018-003666-13 | Sponsor Protocol Number: VAC89220HPX3002 | Start Date*: 2019-10-15 | |||||||||||
| Sponsor Name:Janssen Vaccines & Prevention B.V. | |||||||||||||
| Full Title: A Multi-center, Randomized, Double-blind, Placebo-controlled Phase 3 Efficacy Study of a Heterologous Vaccine Regimen of Ad26.Mos4.HIV and Adjuvanted Clade C gp140 and Mosaic gp140 to Prevent HIV-1... | |||||||||||||
| Medical condition: Prevention of HIV-1 Infection | |||||||||||||
					
						
							
  | 
			|||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: ES (Restarted) PL (Completed) IT (Prematurely Ended) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2015-005045-31 | Sponsor Protocol Number: 55668 | Start Date*: 2016-09-13 | 
| Sponsor Name:Erasmus MC | ||
| Full Title: Switching to Tenofovir Alafenamide Fumarate or ABACavir in patients with Tenofovir Disoproxil Fumarate associated eGFR decline. A randomized clinical trial. | ||
| Medical condition: Renal safety of switching from TDF to TAF or ABC in patients with TDF-associated eGFR-decline. | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2019-004208-37 | Sponsor Protocol Number: S63190 | Start Date*: 2020-08-03 | 
| Sponsor Name:UZ Leuven | ||
| Full Title: Drug repurposing - Statins as microbiota modulating agents in ulcerative colitis | ||
| Medical condition: There are two population groups, 20 healthy volunteers and at least 165 individuals diagnosed with IBD. Either with remission to mild/moderate active ulcerative colitis or remission to mild Crohn's... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2010-018937-23 | Sponsor Protocol Number: SD-QVAR | Start Date*: 2010-05-31 | |||||||||||||||||||||
| Sponsor Name:Medisch Spectrum Twente | |||||||||||||||||||||||
| Full Title: The predictive value of the acute effect of beclomethasone on a mannitol challenge test for the outcome of lomgterm treatment with beclomethasone | |||||||||||||||||||||||
| Medical condition: Exercise induced asthma / bronchoconstriction Asthma | |||||||||||||||||||||||
					
						
							
  | 
			|||||||||||||||||||||||
| Population Age: Adolescents, Under 18 | Gender: Male, Female | ||||||||||||||||||||||
| Trial protocol: NL (Ongoing) | |||||||||||||||||||||||
| Trial results: (No results available) | |||||||||||||||||||||||
| EudraCT Number: 2009-013268-38 | Sponsor Protocol Number: FLUPI-7018 | Start Date*: 2009-09-29 | |||||||||||
| Sponsor Name:AWD.pharma GmbH & Co KG | |||||||||||||
| Full Title: A multicentre, double-blind, randomised, active- and placebo-controlled clinical trial on the pain relieving effects of the modfied-release formulation of flupirtine in patients suffering from mode... | |||||||||||||
| Medical condition: chronic low back pain | |||||||||||||
					
						
							
  | 
			|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: DE (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2019-001969-33 | Sponsor Protocol Number: TAK-242-2001 | Start Date*: 2020-05-28 | |||||||||||
| Sponsor Name:Akaza Bioscience Limited | |||||||||||||
| Full Title: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Proof-of-Concept, Phase 2a Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Intravenous TAK-242 in Subj... | |||||||||||||
| Medical condition: Acute Alcoholic Hepatitis Causing Decompensation of Alcohol related Cirrhosis and Acute-on-Chronic Liver Failure | |||||||||||||
					
						
							
  | 
			|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: GB (GB - no longer in EU/EEA) DE (Prematurely Ended) HU (Prematurely Ended) | |||||||||||||
| Trial results: View results | |||||||||||||
			Subscribe to this Search
To subscribe to the RSS feed for this search click here
			.
			This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
		
			
To subscribe to the RSS feed for this search click here
			.
			This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
		| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
    	Query did not match any studies.